Safety and Efficacy of<i>Para</i>-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Safety and Efficacy ofPara-Aminohippurate Coinfusion for Renal Protection During Peptide Receptor Radiotherapy in Patients with Neuroendocrine Tumors

Published:2024-04-18 Issue:6 Volume:65 Page:931-937
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Moraitis Alexandros,Jentzen Walter,Fragoso Costa Pedro,Kersting David,Himmen Stephan,Coelho Marta,Meckel Marian,van Echteld Cees J.A.,Fendler Wolfgang P.,Herrmann Ken,Sraieb Miriam

Publisher

Society of Nuclear Medicine

Reference40 articles.

1. Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival

2. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

3. Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate

4. 177Lu-[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy

5. Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP